COVID-19 spotlights the threat that cardiovascular disease poses to Americans; new technology may help address risk factors at the population health level.
Although it is a new disease, COVID-19 has a way of peeling back layers and bringing other medical issues to the surface.
For example, research has shown that people with high blood pressure are more likely to become seriously ill.
A study published in the April 22 issue of JAMA of 5,700 patients hospitalized with COVID-19 in the New York City area found that 56% had hypertension, making it the most common comorbidity.
The death rate from cardiovascular disease has been declining, but it remains the leading cause of death in the United States.
According to the CDC, 647,457 Americans died of heart disease and 146,383 of stroke in 2017. (Of course, this year COVID-19 has scrambled the usual list of the leading causes of death in this country.)
“(Cardiovascular disease) has to be a priority of health systems and the government. We haven’t really attacked it as well as we should have,” says Martha Gulati, M.D., M.S., FACC, FAHA, division chief of cardiology at the University of Arizona College of Medicine in Phoenix and editor-in-chief at CardioSmart.org, a […]
read more here —> www.managedhealthcareexecutive.com